Sorafenib Sandoz 400 mg filmom obložene tablete
| Name | Sorafenib Sandoz 400 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-143127575 |
| Active Substance | sorafenibtosilat |
| Composition | Jedna filmom obložena tableta sadrži 400 mg sorafeniba (u obliku tosilata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Remedica Ltd., Limassol, Cipar Lek Pharmaceuticals d.d., Ljubljana, Slovenija PharOS MT Ltd, Birzebbugia, Malta |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 12.05.2021 |
| MA Period of Validity | 12.05.2026 |
| Classification Number | UP/I-530-09/20-01/83 |
| Registration Number | 381-12-01/30-21-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01XE05 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
